517 related articles for article (PubMed ID: 10860553)
21. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
22. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
Ho PC; Saville DJ; Wanwimolruk S
J Pharm Pharm Sci; 2001; 4(3):217-27. PubMed ID: 11737987
[TBL] [Abstract][Full Text] [Related]
24. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
Paine MF; Criss AB; Watkins PB
J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4.
Row EC; Brown SA; Stachulski AV; Lennard MS
Org Biomol Chem; 2006 Apr; 4(8):1604-10. PubMed ID: 16604230
[TBL] [Abstract][Full Text] [Related]
26. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
Paine MF; Criss AB; Watkins PB
Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
[TBL] [Abstract][Full Text] [Related]
27. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Edwards DJ; Bellevue FH; Woster PM
Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
29. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
Desta Z; Soukhova NV; Flockhart DA
Antimicrob Agents Chemother; 2001 Feb; 45(2):382-92. PubMed ID: 11158730
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human drug metabolizing cytochromes P450 by anastrozole, a potent and selective inhibitor of aromatase.
Grimm SW; Dyroff MC
Drug Metab Dispos; 1997 May; 25(5):598-602. PubMed ID: 9152599
[TBL] [Abstract][Full Text] [Related]
32. Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes.
Hanioka N; Ozawa S; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M; Sawada Ji J
Drug Metab Dispos; 2002 Apr; 30(4):391-6. PubMed ID: 11901092
[TBL] [Abstract][Full Text] [Related]
33. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
[TBL] [Abstract][Full Text] [Related]
34. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes.
Girennavar B; Poulose SM; Jayaprakasha GK; Bhat NG; Patil BS
Bioorg Med Chem; 2006 Apr; 14(8):2606-12. PubMed ID: 16338240
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.
Guo LQ; Yamazoe Y
Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198
[TBL] [Abstract][Full Text] [Related]
36. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
Jacobson PA; Green K; Birnbaum A; Remmel RP
Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
[TBL] [Abstract][Full Text] [Related]
37. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
38. Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes.
Park JY; Kim KA; Kim SL
Antimicrob Agents Chemother; 2003 Nov; 47(11):3464-9. PubMed ID: 14576103
[TBL] [Abstract][Full Text] [Related]
39. In vitro effects of tacrolimus on human cytochrome P450.
Lecointre K; Furlan V; Taburet AM
Fundam Clin Pharmacol; 2002 Dec; 16(6):455-60. PubMed ID: 12685503
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
